滑膜组织在脐带间充质干细胞治疗骨关节炎中的作用及机制

doi:10.3969/j.issn.1003-9198.2022.10.006

摘要/Abstract

摘要： 目的探讨骨关节炎(OA)兔滑膜的改变及脐带间充质干细胞(UC-MSCs)对OA的治疗作用及相关机制。方法选取健康成年新西兰大白兔 15只,分为对照组、OA模型组、UC-MSCs干预组3组,每组各5只。OA造模成功后给予干预组关节腔内注射UC-MSCs,干预4周后观察关节影像学改变及病理学改变;取各组滑膜组织通过免疫组化方法检测滑膜组织IL-6、基质金属蛋白酶-13(MMP-13)等炎症因子的水平及细胞外信号调节激酶(ERK)等表达水平,并采用Western blot方法检测滑膜组织IL-6、MMP-13、ERK、丝裂原活化蛋白激酶(MAPK)蛋白等表达水平。结果磁共振检查显示,与对照组相比,OA模型组兔膝关节滑膜明显增厚,关节腔积液明显增多;UC-MSCs干预组关节滑膜增厚、关节腔积液均较OA模型组明显改善。病理学观察显示,OA模型组关节滑膜炎性细胞较对照组明显增多,滑膜增生、水肿明显,UC-MSCs干预组较OA模型组滑膜炎性细胞浸润减轻,滑膜增生、水肿明显减轻。免疫组化结果显示,OA模型组兔滑膜IL-6、MMP-13、ERK水平较对照组明显升高(P＜0.05)。UC-MSCs干预组ERK、MMP-13水平较OA模型组下降,差异有统计学意义(P＜0.05),IL-6水平较OA模型组下降不明显,差异无统计学意义(P＞0.05)。Western blot结果显示,模型组IL-6、MMP-13、MAPK、ERK表达水平均较对照组明显升高,差异有统计学意义(P＜0.05);UC-MSCs干预组IL-6、MMP-13、MAPK、ERK表达量较OA模型组明显下降(P＜0.05)。结论 OA病程中存在滑膜组织炎症反应改变,滑膜的炎症因子参与OA形成及进展;UC-MSCs对OA兔滑膜具有保护作用,与其抑制炎症反应相关。

关键词: 骨关节炎, 间充质干细胞, 滑膜

Abstract: Objective To investigate the changes of synovial membrane in osteoarthritis(OA),and to investigate the therapeutic effect of umbilical cord mesenchymal stem cells (UC-MSCs) on OA through synovial membrane and the related mechanism. Methods Fifteen healthy adult New Zealand white rabbits were selected and divided into 3 groups, including control group, OA model group and UC-MSCs intervention group, with five rabbits in each group. After successful OA modeling, intra-articular injection of UC-MSCs was given to UC-MSCs intervention group. Imaging and pathological changes of the joints were observed after 4 weeks of treatment. The expression levels of interleukin-6(IL-6), matrix metalloproteinase-13(MMP-13)and extracellular signal regulated kinase(ERK) proteins in the synovial tissues of rabbits in each group were detected by immunohistochemistry and the protein expression levels of IL-6, MMP-13, ERK and mitogen-activated protein kinase (MAPK) in the synovial tissues of rabbits were detected by Western blot. Results Magnetic resonance examination showed that compared with control group, the synovium of the knee joint in OA model group was significantly thickened and the effusion of the joint cavity was significantly increased; Synovial thickening and joint effusion were significantly improved in UC-MSCs intervention group compared with OA model group. Pathological results showed that the number of synovial inflammatory cells and synovial hyperplasia and edema were significantly increased in OA model group compared with control group. Compared with OA model group, the infiltration of synovial inflammatory cells and synovial hyperplasia and edema were significantly reduced in UC-MSCs intervention group. The levels of ERK, IL-6 and MMP-13 in synovial membrane of rabbit in OA model group were significantly higher than those in control group (P<0.05).The levels of ERK and MMP-13 in UC-MSCs intervention group were decreased compared with OA model group (P<0.05).Western blot analysis showed that the expression levels of IL-6, MMP-13, MAPK and ERK in OA model group were significantly higher than those in control group (P<0.05), while significantly decreased in UC-MSCs intervention group (P<0.05). Conclusions Inflammatory factors of synovial tissue are involved in the formation and progression of OA.UC-MSCs has a protective effect on the synovial membrane of OA, which is related to the inhibition of inflammatory response.

Key words: osteoarthritis, mesenchymal stem cells, synovial membrane

中图分类号:

R684.3

曹娟, 姚瑶, 李玲玲, 武文卉, 肖云云, 丁从珠. 滑膜组织在脐带间充质干细胞治疗骨关节炎中的作用及机制[J]. 实用老年医学, 2022, 36(10): 996-1000.

CAO Juan, YAO Yao, LI Ling-ling, WU Wen-hui, XIAO Yun-yun, DING Cong-zhu. Role and the mechanism of synovial tissue in the treatment of osteoarthritis by mesenchymal stem cells[J]. Practical Geriatrics, 2022, 36(10): 996-1000.

参考文献

[1] 廖德发.我国骨性关节炎流行病学调查现状[J].微创医学, 2017, 12(4):521-524.
[2] BERENBAUM F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)[J].Osteoarthritis Cartilage, 2013,21(1):16-21.
[3] WYLES C C, HOUDEK M T, BEHFAR A, et al. Mesenchymal stem cell therapy for osteoarthritis: current perspectives[J]. Stem Cells Cloning, 2015,8:117-124.
[4] GLENN J D, WHARTENBY K A. Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy[J].World J Stem Cells, 2014, 6(5):526-539.
[5] 曹娟,丁从珠,陆邦超,等.脐带间质干细胞对骨关节炎的治疗作用及机制研究[J].中华老年医学杂志,2018,37(1):79-83.
[6] SOHN D H, SOKOLOVE J, SHARPE O, et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4 [J]. Arthritis Res Ther, 2012,14(1):R7.
[7] NOSKOVA A S, KRASIVINA I G, DOLGOVA L N, et al. Abdominal obesity--factor contributing to osteoarthrosis of the knee joints[J]. Ter Arkh, 2007,79(5): 29-31.
[8] CHEN Y H, CARRINO J A, RAMAN S P, et al. Atraumatic lateral collateral ligament complex signal abnormalities by magnetic resonance imaging in patients with osteoarthrosis of the knee[J]. J Comput Assist Tomogr, 2008,32(6):982-986.
[9] CAMEJO F, ALMEIDA L E, DOETZER A D, et al. FasL expression in articular discs of human temporomandibular joint and association with osteoarthrosis[J].Oral Pathol Med, 2014, 43(1):69-75.
[10] GUERMAZI A, HAYASHI D, ROEMER F W, et al. Synovitis in knee osteoarthritis assessed by contrast-enhanced magnetic resonance imaging (MRI) is associated with radiographic tibiofemoral osteoarthritis and MRI-detected widespread cartilage damage: the MOST study[J]. J Rheumatol,2014, 41(3):501-508.
[11] FELSON D T, NIU J, NEOGI T, et al. Synovitis and the risk of knee osteoarthritis: the MOST study[J]. Osteoarthritis Cartilage, 2016, 24(3):458-464.
[12] KURYLISZYN-MOSKAL A. Comparison of blood and synovial fluid lymphocyte subsets in rheumatoid arthritis and osteoarthritis[J]. Clin Rheumatol,1995,14(1):43-50.
[13] 李跃军,朱卫国,方钦正,等. 骨关节炎滑膜组织中β-catenin和基质金属蛋白酶13的临床意义[J].中国组织工程研究,2018,22(16):2472-2477.
[14] 李保驰,王维山,董金波,等. MMP-3、MMP-13 在骨性关节炎患者滑膜中的表达及意义[J].中国骨质疏松杂志,2014,20(6):593-596.
[15] PIECHA D, WEIK J, KHEIL H, et al. Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular andhuman osteoarthritis cartilage explants[J]. Inflamm Res, 2010, 59(5):379-389.
[16] 师婕,张钰,许秀峰,等.探究早期兔膝骨关节炎中ERK信号通路对细胞自噬的作用[J].中国康复,2020,35(1):3-6.
[17] ZHOU F, MEI J T, HAN X G, et al. Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-κB/MAPK signaling and protecting chondrocytes[J]. Acta Pharm Sin B, 2019,9(5):973-985.
[18] GUO S Y, NI Y Y, BEN J J, et al. Class a scavenger receptor exacerbates osteoclastogenesis by an interleukin-6-mediated mechanism through ERK and JNK signaling pathways[J]. Int J Biol Sci, 2016, 12(10):1155-1167.
[19] 杨丰建,俞永林,夏军,等.基质金属蛋白酶-1/13与信号通路激酶ERK1/2在兔骨关节炎软骨中的表达[J].老年医学与保健,2007,13(6):338-342.
[20] DE BARI C,ROELOFS A J. Stem cell-based therapeutic strategiesfor cartilage defects and steoarthritis [J]. Curr Opin Pharmacol, 2018, 40:74-80.